The closing price of Larimar Therapeutics Inc (NASDAQ: LRMR) was $10.20 for the day, down -6.59% from the previous closing price of $10.92. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 530725 shares were traded.
Ratios:
Our analysis of LRMR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.02 and its Current Ratio is at 15.02. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On October 19, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 16 ’24 when Flynn James E bought 4,290,617 shares for $8.74 per share. The transaction valued at 37,499,993 led to the insider holds 6,151,406 shares of the business.
THOMAS FRANK E bought 2,000 shares of LRMR for $22,000 on Feb 14 ’24. The Director now owns 2,000 shares after completing the transaction at $11.00 per share. On Dec 07 ’23, another insider, Shankar Gopi, who serves as the Chief Development Officer of the company, bought 5,000 shares for $3.73 each. As a result, the insider paid 18,662 and bolstered with 5,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 649.16M and an Enterprise Value of 558.96M.
Stock Price History:
Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $2.18. The 50-Day Moving Average of the stock is 7.47, while the 200-Day Moving Average is calculated to be 4.53.
Shares Statistics:
LRMR traded an average of 469.64K shares per day over the past three months and 349.27k shares per day over the past ten days. A total of 43.27M shares are outstanding, with a floating share count of 25.84M. Insiders hold about 41.14% of the company’s shares, while institutions hold 64.47% stake in the company. Shares short for LRMR as of Feb 15, 2024 were 618.2k with a Short Ratio of 1.32, compared to 357.11k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.41% and a Short% of Float of 2.38%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.25 for the current quarter, with a high estimate of -$0.22 and a low estimate of -$0.28, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.19 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$0.56 and -$0.86 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$1.47, with 4 analysts recommending between -$1.28 and -$1.73.
